709 related articles for article (PubMed ID: 30923679)
1. The emerging role of cell-free DNA as a molecular marker for cancer management.
Bronkhorst AJ; Ungerer V; Holdenrieder S
Biomol Detect Quantif; 2019 Mar; 17():100087. PubMed ID: 30923679
[TBL] [Abstract][Full Text] [Related]
2. Liquid biopsy: current technology and clinical applications.
Nikanjam M; Kato S; Kurzrock R
J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
[TBL] [Abstract][Full Text] [Related]
3. Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook.
Ng CKY; Di Costanzo GG; Terracciano LM; Piscuoglio S
Front Med (Lausanne); 2018; 5():78. PubMed ID: 29632864
[TBL] [Abstract][Full Text] [Related]
4. Preanalytical variables that affect the outcome of cell-free DNA measurements.
Ungerer V; Bronkhorst AJ; Holdenrieder S
Crit Rev Clin Lab Sci; 2020 Nov; 57(7):484-507. PubMed ID: 32393081
[TBL] [Abstract][Full Text] [Related]
5. The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples.
Peng H; Pan M; Zhou Z; Chen C; Xing X; Cheng S; Zhang S; Zheng H; Qian K
Front Cell Dev Biol; 2024; 12():1385041. PubMed ID: 38784382
[TBL] [Abstract][Full Text] [Related]
6. Size distribution of cell-free DNA in oncology.
Udomruk S; Orrapin S; Pruksakorn D; Chaiyawat P
Crit Rev Oncol Hematol; 2021 Oct; 166():103455. PubMed ID: 34464717
[TBL] [Abstract][Full Text] [Related]
7. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology.
Ray SK; Mukherjee S
Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128
[TBL] [Abstract][Full Text] [Related]
8. Cell-free DNA: Preanalytical variables.
Bronkhorst AJ; Aucamp J; Pretorius PJ
Clin Chim Acta; 2015 Oct; 450():243-53. PubMed ID: 26341895
[TBL] [Abstract][Full Text] [Related]
9. Cell-Free DNA Fragmentomics in Liquid Biopsy.
Ding SC; Lo YMD
Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35454026
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsies based on cell-free DNA as a potential biomarker in head and neck cancer.
Rapado-González Ó; Rodríguez-Ces AM; López-López R; Suárez-Cunqueiro MM
Jpn Dent Sci Rev; 2023 Dec; 59():289-302. PubMed ID: 37680614
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy in Retinoblastoma: A review.
Ghose N; Kaliki S
Semin Ophthalmol; 2022; 37(7-8):813-819. PubMed ID: 35604935
[TBL] [Abstract][Full Text] [Related]
12. The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies.
Gezer U; Bronkhorst AJ; Holdenrieder S
Diagnostics (Basel); 2022 Jun; 12(6):. PubMed ID: 35741173
[TBL] [Abstract][Full Text] [Related]
13. A Targeted Q-PCR-Based Method for Point Mutation Testing by Analyzing Circulating DNA for Cancer Management Care.
Thierry AR
Methods Mol Biol; 2016; 1392():1-16. PubMed ID: 26843041
[TBL] [Abstract][Full Text] [Related]
14. New Perspectives on the Importance of Cell-Free DNA Biology.
Bronkhorst AJ; Ungerer V; Oberhofer A; Gabriel S; Polatoglou E; Randeu H; Uhlig C; Pfister H; Mayer Z; Holdenrieder S
Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140548
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.
Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R
Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301
[TBL] [Abstract][Full Text] [Related]
16. 'Longing' for the Next Generation of Liquid Biopsy: The Diagnostic Potential of Long Cell-Free DNA in Oncology and Prenatal Testing.
Yu SCY; Choy LYL; Lo YMD
Mol Diagn Ther; 2023 Sep; 27(5):563-571. PubMed ID: 37474843
[TBL] [Abstract][Full Text] [Related]
17. Technical considerations for circulating tumor DNA detection in oncology.
Franczak C; Filhine-Tresarrieu P; Gilson P; Merlin JL; Au L; Harlé A
Expert Rev Mol Diagn; 2019 Feb; 19(2):121-135. PubMed ID: 30648442
[TBL] [Abstract][Full Text] [Related]
18. Potential of modern circulating cell-free DNA diagnostic tools for detection of specific tumour cells in clinical practice.
Gašperšič J; Videtič Paska A
Biochem Med (Zagreb); 2020 Oct; 30(3):030504. PubMed ID: 32774122
[TBL] [Abstract][Full Text] [Related]
19. Cell-Free DNA and Apoptosis: How Dead Cells Inform About the Living.
Heitzer E; Auinger L; Speicher MR
Trends Mol Med; 2020 May; 26(5):519-528. PubMed ID: 32359482
[TBL] [Abstract][Full Text] [Related]
20. The application of circulating tumor cell and cell-free DNA liquid biopsies in ovarian cancer.
Balla A; Bhak J; Biró O
Mol Cell Probes; 2022 Dec; 66():101871. PubMed ID: 36283501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
